The latest from TV, Radio, and Newspapers

Add a news source

Are we missing a Schaumburg news source? Let us know!

Schaumburg Newswire

Schaumburg Newswire

Comprehensive Real-Time News Feed for Schaumburg, IL.

Results 1 - 17 of 17 for "u:americanbankingnews.com" in Schaumburg, IL

  1. Sagent Pharmaceuticals (SGNT) - Investment Analysts' Weekly Ratings ChangesRead the original story w/Photo

    Jul 25, 2016 | AmericanBankingNews.com

    They now have a $24.00 price target on the stock. According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals.

    Comment?

  2. Analysts' Recent Ratings Updates for Sagent PharmaceuticalsRead the original story w/Photo

    Jul 13, 2016 | AmericanBankingNews.com

    They now have a $24.00 price target on the stock. According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals.

    Comment?

  3. Analysts' Recent Ratings Updates for Sagent PharmaceuticalsRead the original story w/Photo

    Jul 13, 2016 | AmericanBankingNews.com

    They now have a $24.00 price target on the stock. According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals.

    Comment?

  4. Sagent Pharmaceuticals Inc. (SGNT) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Jul 12, 2016 | AmericanBankingNews.com

    The firm currently has a $24.00 price target on the stock. Zacks Investment Research's price objective would indicate a potential upside of 10.85% from the company's previous close.

    Comment?

  5. Sagent Pharmaceuticals Inc. (SGNT) Rating Increased to Buy at Zacks Investment ResearchRead the original story w/Photo

    Jul 12, 2016 | AmericanBankingNews.com

    The firm currently has a $24.00 price target on the stock. Zacks Investment Research's price objective would indicate a potential upside of 10.85% from the stock's previous close.

    Comment?

  6. Analysts' Weekly Ratings Changes for Sagent PharmaceuticalsRead the original story w/Photo

    Jun 22, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  7. Sagent Pharmaceuticals Inc (SGNT) Upgraded at Zacks Investment ResearchRead the original story w/Photo

    Jun 22, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  8. Sagent Pharmaceuticals Inc (SGNT) Upgraded to "Hold" by Zacks Investment ResearchRead the original story w/Photo

    Jun 22, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  9. Sagent Pharmaceuticals Inc (SGNT) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Jun 10, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  10. Sagent Pharmaceuticals Inc (SGNT) Lowered to "Sell" at Zacks Investment ResearchRead the original story w/Photo

    Jun 10, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  11. Equities Research Analysts' Upgrades for May, 28th (NK, NVAX,...Read the original story w/Photo

    May 28, 2016 | AmericanBankingNews.com

    According to Zacks, "NantKwest, Inc. is a clinical-stage immunotherapy company. The Company's product candidates include aNK, haNK and taNK for the treatment of cancers, infectious and inflammatory diseases.

    Comment?

  12. Sagent Pharmaceuticals Inc (SGNT) Upgraded to Hold by Zacks Investment ResearchRead the original story w/Photo

    May 28, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  13. Sagent Pharmaceuticals Inc (SGNT) Lifted to Hold at Zacks Investment ResearchRead the original story w/Photo

    May 28, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  14. Sagent Pharmaceuticals (SGNT) - Investment Analysts' Weekly Ratings ChangesRead the original story w/Photo

    May 24, 2016 | AmericanBankingNews.com

    They now have a $13.00 price target on the stock. 5/5/2016 - Sagent Pharmaceuticals was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

    Comment?

  15. Investment Analysts' Weekly Ratings Changes for Sagent PharmaceuticalsRead the original story w/Photo

    May 12, 2016 | AmericanBankingNews.com

    Several brokerages have updated their recommendations and price targets on shares of Sagent Pharmaceuticals in the last few weeks: 5/9/2016 - Sagent Pharmaceuticals had its "hold" rating reaffirmed by analysts at Bank of America. They now have a $13.00 price target on the stock.

    Comment?

  16. Sagent Pharmaceuticals Inc (SGNT) Lowered to "Sell" at Zacks Investment ResearchRead the original story w/Photo

    May 8, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

  17. Sagent Pharmaceuticals Inc (SGNT) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    May 5, 2016 | AmericanBankingNews.com

    According to Zacks, "Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags.

    Comment?

Schaumburg Job Listings
View or post Schaumburg job listings on Topix.
Schaumburg Real Estate
News, listings, and foreclosures in Schaumburg from Topix.
Schaumburg Mortgages
Find mortgage rates in Schaumburg on Topix.